Viewing Study NCT06334120


Ignite Creation Date: 2025-12-25 @ 4:25 AM
Ignite Modification Date: 2025-12-26 @ 3:29 AM
Study NCT ID: NCT06334120
Status: RECRUITING
Last Update Posted: 2025-12-05
First Post: 2024-03-21
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: An Observational Study to Learn More About the Safety of Darolutamide in Men With Prostate Cancer in Korea
Sponsor: Bayer
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-09-25
Start Date Type: ACTUAL
Primary Completion Date: 2028-03-31
Primary Completion Date Type: ESTIMATED
Completion Date: 2028-06-30
Completion Date Type: ESTIMATED
First Submit Date: 2024-03-21
First Submit QC Date: None
Study First Post Date: 2024-03-27
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-12-03
Last Update Post Date: 2025-12-05
Last Update Post Date Type: ESTIMATED